New directions in metabolic engineering

Current Opinion in Chemical Biology

Volumn 2, Issue 1, 1998, Pages 133-137

  Jacobsen, John R ^a   Khosla, Chaitan ^b  

^a Stanford University   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; HUMAN; METABOLISM; REVIEW;

BIOTECHNOLOGY; HUMANS; METABOLISM;

EID: 0031995123     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(98)80045-8     Document Type: Article

References (43)

1. Mermelstein LD, Welker NE, Bennett GN, Papoutsakis ET: Expression of cloned homologous fermentive genes in Clostridium acetobutylicum ATCC 824. Biotechnology 1992, 10:190-195.
2. Mermelstein LD, Papoutsakis ET: In vivo methylation in Escherichia coli by the Bacillus subtilis phage ø3T methyltransferase to protect plasmids from restriction upon transformation of Clostridium acetobutylicum ATCC 824. Appl Environ Microbiol 1993, 59:1077-1081.
3. Mermelstein LD, Papoutsakis ET, Petersen DJ, Bennett GN: Metabolic engineering of Clostridium acetobutylicum ATCC 824 for increased solvent production by enhancement of acetone formation enzyme activities using a synthetic acetone operon. Biotechnol Bioeng 1993, 42:1053-1060.
4. Green EM, Boynton ZL, Harris LM, Rudolf FB, Papoutsakis ET, Bennett GN: Genetic manipulation of acid formation pathways by gene inactivation in Clostridium acetobutylicum ATCC 824. Microbiology 1996, 142:2079-2086.
5. Zhang M, Eddy C, Deanda K, Finkelstein M, Picataggio S: Metabolic engineering of a pentose metabolism pathway in ethanologenic Zymomonas mobilis. Science 1995, 267:240-243.
6. Deanda K, Zhang M, Eddy C, Picataggio S: Development of an arabinose-fermenting Zymomonas mobilis strain by metabolic pathway engineering. Appl Environ Microbiol 1996, 62:4465-4470. Although Zymomonas mobilis efficiently ferments the glucose component of lignocellulosic feedstock to ethanol, it lacks the pathways for pentose metabolism necessary for efficient utilization of these feedstocks, Introduction of the genes for arabinose metabolism allowed the engineered organism to metabolize this pentose. This work complements previous experiments in which the xylose metabolic pathway was introduced into this organism, and represents a promising approach to the efficient utilization of lignocellulosic biomass, a low-cost renewable resource.
7. Lee SY: Bacterial polyhydroxyalkanoates. Biotechnol Bioeng 1996, 49:1-14.
8. Hahn SK, Chang YK, Lee SY: Recovery and characterization of poly(3-hydroxybutyric acid) synthesized in Alcaligenes eutrophus and recombinant Escherichia coli. Appl Environ Microbiol 1995, 61:34-39.
9. Poirier Y, Dennis DE, Klomparens K, Somerville C: Polyhydroxybutyrate, a biodegradable thermoplastic, produced in transgenic plants. Science 1992, 256:520-523.
10. Nawrath C, Poirier Y, Somerville C: Targeting of the Polyhydroxybutyrate pathway to the plastids of Arabidopsis thaliana results in high levels of polymer accumulation. Proc Natl Acad Sci USA 1994, 91:12760-12764.
11. John ME, Keller G: Metabolic pathway engineering in cotton: Biosynthesis of Polyhydroxybutyrate in fiber cells. Proc Natl Acad Sci USA 1996, 93:12768-12773. The Polyhydroxybutyrate synthesis pathway was expressed in cotton fiber cells and the resulting transgenic fibers were shown to contain low levels of PHB. Even at low levels, the PHB conferred measurably improved insulating properties to the fiber.
12. Yim KS, Lee SY, Chang HN: Synthesis of poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) by recombinant Escherichia coli. Biotechnol Bioeng 1996, 49:495-503.
13. Sim SJ, Snell KD, Hogan SA, Stubbe J, Rha C, Sinskey AJ: PHA synthase activity controls the molecular weight and polydispersity of polyhydroxybutyrate in vivo. Nat Biotechnol 1997, 15:63-67. Average molecular weight and molecular weight distribution are extremely important in determining the physical properties of a polymer. In this report, it is demonstrated that average weight and polydispersity of bacterially produced PHB are affected by the expression level of polyhydroxyalkanoate synthase, the enzyme responsible for polymerization of the monomers. The average weight is inversely proportional to the expression level of the syn thase, suggesting a model in which each enzyme unit is responsible for the synthesis of a single polymer chain. This provides a useful method for controlling the physical properties of PHB.
14. Dell KA, Frost JW: Identification and removal of impediments to biocatalytic synthesis of aromatics from D-glucose: rate limiting enzymes in the common pathway of aromatic amino acid biosynthesis. J Am Chem Soc 1993, 115:11581-11589.
15. Snell KD, Draths KM, Frost JW: Enhancing the biocatalytic conversion of glucose into aromatic chemicals. J Am Chem Soc 1996, 118:5605-5614.
16. Draths KM, Pompliano DL, Conley DL, Frost JW, Berry A, Disbrow GL, Straversky RJ, Lievense JC: Biocatalytic synthesis of aromatics from D-glucose: the role of transketolase. J Am Chem Soc 1992, 114:3956-3962.
17. 7. Patnaik R, Spitzer RG, Liao JC: Pathway engineering for production of aromatics in Escherichia coli: confirmation of stoichiometric analysis by independent modulation of AroG, TktA and Pps activities. Biotechnol Bioeng 1995, 46:361-370.
18. Lu J-L, Liao JC: Metabolic engineering and control analysis for production of aromatics: role of transaldolase. Biotechnol Bioeng 1997, 53:132-138.
19. Flores N, Xiao J, Berry A, Bolivar F, Valle F: Pathway engineering for the production of aromatic compounds in Escherichia coli. Nat Biotechnology 1996, 14:620-623. Microbial production of aromatic compounds may be improved by directing the maximal amount of metabolic flux through DAHP and into aromatic amino acid biosynthesis. This report describes a method for increasing the amount of PEP available for DAHP synthesis. The E. coli PTS utilizes one molecule of PEP for each molecule of glucose imported. By mutational inactivation of the PTS and selection for growth on glucose, mutant strains were obtained that internalize glucose by a non-PTS system while maintaining wild-type growth rates. Higher levels of DAHP production are observed, presumably due to a larger available supply of PEP.
20. A with, negligible drop in overall production. This demonstrates an application of metabolic engineering to secondary metabolism in order to increase the production of a high-value product.
21. Stachelhaus T, Schneider A, Marahiel MA: Rational design of peptide antibiotics by targeted replacement of bacterial and fungal domains. Science 1995, 269:69-72.
22. Khosla C, Zawada RJX: Generation of polyketide libraries via combinatorial biosynthesis. Trends Biotechnol 1996, 14:335-341.
23. Oliynyk M, Brown MJB, Cortés J, Staunton J, Leadlay PF: A hybrid modular polyketide synthase obtained by domain swapping. Chem Biol 1996, 3:833-839.
24. Ruan X, Pereda A, Stassi DL, Zeidner D, Summers RG, Jackson M, Shivakumar A, Kakavas S, Staver MJ, Donadio S, Katz L: Acyltransferase domain substitutions in the erythromycin polyketide synthase yield novel erythromycin derivatives. J Bacteriol 1997, 179:6416-6425.
25. Liu L, Thamchaipenet A, Fu H, Betlach M, Ashley G: Biosynthesis of 2-nor-deoxyerythromycin B by rationally designed domain substitution. J Am Chem Soc 1997, 119:10553-10554.
26. Kao CM, McPherson M, McDaniel RN, Fu H, Cane DE, Khosla C: Gain of function mutagenesis of the erythromycin polyketide synthase. 2. Engineered biosynthesis of an eight-membered ring tetraketide lactone. J Am Chem Soc 1997, 119:11339-11340. The modular nature of deoxyerythronolide B synthase suggests that new functions may be engineered by rational domain substitutions. In this report, two domains from another polyketide synthase were inserted into DEBS, and new catalytic functions were added. Where the wild-type enzyme produces a hydroxyl group, the engineered strain carries out two additional catalytic steps to generate a methylene group. This has the additional effect of allowing the product to form a novel eight-membered ring structure. This work is an excellent example of engineering new metabolic products by manipulation of a modular biosynthetic pathway.
27. Jacobsen JR, Hutchinson CR, Cane DE, Khosla C: Precursor-directed biosynthesis of erythromycin analogs by an engineered polyketide synthase. Science 1997, 277:367-369. A genetic block was introduced into the erythromycin biosynthesis pathway. The engineered pathway requires an exogenous supply of synthetic intermediates and will utilize 'unnatural' precursors to generate corresponding analogs of erythromycin, some of which display antibiotic activity. This demonstrates the effective combination of metabolic engineering and organic synthesis in order to generate analogs of erythromycin and other structurally complex polyketide products.
28. Khosla C, Bailey JE: Heterologous expression of a bacterial haemoglobin improves the growth properties of recombinant Escherichia coli. Nature 1988, 331:633-635.
29. Tsai PS, Hatzimanikatis V, Bailey JE: Effect of Vitreoscilla hemoglobin dosage on microaerobic Escherichia coli carbon and energy metabolism. Biotechnol Bioeng 1996, 49:139-150.
30. Varma A, Palsson BO: Metabolic flux balancing: basic concepts, scientific and practical use. Bio-Technology 1994, 12:994-998.
31. Tsai PS, Nägeli M, Bailey JE: Intracellular expression of Vitreoscilla hemoglobin modifies microaerobic Escherichia coli metabolism through elevated concentration and specific activitiy of cytochrome o. Biotechnol Bioeng 1996, 49:151-160. Expression of VHb in E. coli and other organisms appears to increase the amount of oxygen available for metabolic processes. This paper shows that this observed effect is mediated by increased expression and activity of cyt o, a terminal oxidase in the electron transport chain with relatively low oxygen affinity. A second terminal oxidase, cyt d, displays higher oxygen affinity but lower proton-pumping efficiency and is normally active under low oxygen conditions. VHb increases both the expression and apparent oxygen affinity of cyt o, improving microaerobic respiration and growth.
32. Magnolo SK, Leenutaphong DL, DeModena JA, Curtis JE, Bailey JE, Galazzo JL, Hughes DE: Actinorhodin production by Streptomyces coelicolor and growth of Streptomyces lividans are improved by the expression of a bacterial hemoglobin. Bio-Technology 1991, 9:473-476.
33. DeModena JA, Gutiérrez S, Velasco J, Fernández FJ, Fachini RA, Galazzo JL, Hughes DE, Martin JF: The production of cephalosporin C by Acremonium chrysogenum is improved by the intracellular expression of a bacterial hemoglobin. Bio-Technology 1993, 11:926-929.
34. Liu S-C, Webster DA, Wei M-L, Stark BC: Genetic engineering to contain the Vitreoscilla hemoglobin gene enhances degradation of benzoic acid by Xanthomonas maltophilia. Biotechnol Bioeng 1996, 49:101-105.
35. Holmberg N, Lilius G, Bailey JE, Bülow L: Transgenic tobacco expressing Vitreoscilla hemoglobin exhibits enhanced growth and altered metabolic production. Nat Biotechnol 1997, 15:244-247. Expression of VHb in tobacco plants was shown to have several beneficial effects. Chlorophyll production increased 30-40% in the transgenic plants, possibly resulting from an increase in oxygen available for its biosynthesis. Nicotine production, which is oxygen dependent, was also increased at the expense of oxygen-independent production of anabasine.
36. Sonnewald U, Hajirezaei M-R, Kossmann J, Heyer A, Trethewey RN, Willmitzer L: Increased potato tuber size resulting from apoplastic expression of a yeast invertase. Nat Biotechnol 1997, 15:794-797.
37. Lee KH, Harrington MG, Bailey JE: Two-dimensional electrophoresis of proteins as a tool in the metabolic engineering of cell cycle regulation. Biotechnol Bioeng 1996, 50:336-340.
38. Lee KH, Sburlati A, Renner WA, Bailey JE: Deregulated expression of cloned transcription factor E2F-1 in Chinese hamster ovary cells shifts protein patterns and activates growth in protein-free medium. Biotechnol Bioeng 1996, 50:273-279. In this report, a metabolic engineering approach was taken to eliminate the costly and inconvenient requirement for animal serum in mammalian cell culture. Recent advances in the understanding of the cell cycle suggested that deregulated expression of the transcription factor E2F-1 would bypass the requirement for growth factors normally obtained from serum. CHO cells were transfected with E2F-1 and the resulting overexpression of this protein allowed the cells to grow in serum-free media.
39. Renner WA, Lee KH, Hatzimanikatis V, Bailey JE, Eppenberger HM: Recombinant cyclin E expression activates proliferation and obviates surface attachment in Chinese hamster ovary (CHO) cells in protein-free medium. Biotechnol Bioeng 1995, 47:476-482.
40. Bailey JE: Metabolic engineering. Adv Mol Cell Biol 1996, 15A:289-296.
41. Mahal LK, Yarema KJ, Bertozzi CR: Engineering chemical reactivity on cell surfaces through oligosaccharide biosynthesis. Science 1997, 276:1125-1128. The intrinsic promiscuity of glycosyl transferases was exploited to re-engineer cell surface carbohydrates. Using a chemical approach, synthetic carbohydrates bearing a reactive ketone group were incorporated metabolically into cell-surface oligosaccharides. Chemoselective reactions carried out on the engineered cell surface allowed the introduction of new epitopes for the modulation of cellular recognition. This was demonstrated by an example of selective drug delivery. This approach demonstrates metabolic engineering through chemistry rather than genetic alteration.
42. Crameri A, Dawes G, Rodriguez E Jr, Silver S, Stemmer WPC: Molecular evolution of an arsenate detoxification pathway by DNA shuffling. Nat Biotechnol 1997, 15:436-438. This study demonstrates a nonrational approach to the metabolic engineering of E. coli to improve resistance to the toxic effects of arsenate. DNA shuffling is a method for recombining and selecting advantageous mutations, allowing rapid evolution of function. Starting with a plasmid-borne arsenic resistance operon, three cycles of fragmentation and recombination afforded a 40-fold increase in resistance. Sequencing of the genes revealed a small number of mutations; however, the mechanism by which these mutations confer improvement remains unknown. A major advantage of this nonrational approach to engineering is its ability to optimize the function of genes without detailed understanding of the metabolic pathways.
43. Stemmer WPC: DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution. Proc Natl Acad Sci USA 1994, 91:10747-10751.